Laatste update :
19/11/2024
Antibioticum   Cefamandole nafate  
injecteerbaar geneesmiddel
Stabiliteit in oplossing Stabiliteit in mengsels Factoren die de stabiliteit beïnvloeden Verenigbaarheden Toedieningswijze Literatuur pdf
   Molecuulstructuur  

Merknamen in verschillende landen   Merknamen in verschillende landen     

Handelsnamen zijn slechts een indicatie; de samenstelling van hulpstoffen kan per land variëren afhankelijk van de fabrikant

Acemycin Griekenland
Cefam Hongarije, Italië
Cefamandol Luxemburg
Cefamandolo Italië
Cemado Italië
Kefadol Ierland
Kefandol Groot Britannië, Marokko
Lampomandol Italië
Mancef Italië
Mandokef Griekenland, Hongarije, Italië, Oostenrijk, Zwitserland
Mandol Australië, Luxemburg, Nederland, nieuw Zeeland, Verenigde Arabische Emiraten
Mandolsan Italië
Septomandolo Italië
Tarcefandol Polen
Literatuur   injecteerbaar geneesmiddel   Literatuur : Cefamandole nafate  
type publicatie
198 Artikel Gayed AA, Kheshary PR, Hinkle RL.
Visual compatibility of diltiazem injection with various diluents and medications during simulated Y-site injection.
Am J Health-Syst Pharm 1995 ; 52: 516-520.
336 Artikel Forman JK, Lachs JR, Souney PF.
Visual compatibility of acyclovir sodium with commonly used intravenous drugs during simulated Y-site injection.
Am J Hosp Pharm 1987 ; 44: 1408-1409.
385 Artikel Benedict MK, Roche VF, Banakar UV, Hilleman DE.
Visual compatibility of amiodarone hydrochloride with various antimicrobial agents during simulated Y-site injection.
Am J Hosp Pharm 1988 ; 45: 1117-1118.
405 Artikel Nieves-Cordero AL, Luciw HM, Souney PF.
Compatibility of narcotic analgesic solutions with various antibiotics during simulated Y-site injection.
Am J Hosp Pharm 1985 ; 42: 1108-1109.
406 Artikel Smythe MA, Patel MA, Gasloli RA.
Visual compatibility of narcotic analgesics with selected intravenous admixtures.
Am J Hosp Pharm 1990 ; 47: 819-820.
418 Artikel Bosso JA, Townsend RJ.
Stability of clindamycin phosphate and ceftizoxime sodium, cefoxitine sodium, cefamandole nafate, or cefazolin sodium in two intravenous solutions.
Am J Hosp Pharm 1985 ; 42: 2211-2214.
472 Artikel Wohlford JG, Fowler MD.
Visual compatibility of hetastarch with injectable critical-care drugs.
Am J Hosp Pharm 1989 ; 46: 995-996.
574 Artikel Kleinberg ML, Stauffer GL, Prior RB, Latiolais CJ.
Stability of antibiotics frozen and stored in disposable hypodermic syringes.
Am J Hosp Pharm 1980 ; 37: 1087-1088.
576 Artikel Holmes CJ, Ausman RK, Walter CW, Kundsin RB.
Activity of antibiotic admixtures subjected to different freeze-thaw treatments.
Drug Intell Clin Pharm 1980 ; 14: 353-357.
604 fabrikant Stabilité des médicaments dans l'Intermate® SV50, 100, 200
Baxter 1998
612 Artikel Frable RA, Klink PR, Engel GL, Mundell EE.
Stability of cefamandole nafate injection with parenteral solutions and additives.
Am J Hosp Pharm 1982 ; 39: 622-627.
630 Artikel Das Gupta V, Stewart KR.
Stability of metronidazole and ten antibiotics when mixed with magnesium sulphate solutions.
J Clin Hosp Pharm 1985 ; 10: 67-72.
999 Artikel Watson D.
Piggyback compatibility of antibiotics with pediatric parenteral nutrition solution.
JPEN 1985 ; 9: 220-224.
1035 Artikel Bisaillon S, Sarrazin R.
Compatibility of several antibiotics or hydrocortisone when added to metronidazole solution for intravenous infusion.
J Parenter Sci Technol 1983 ; 37: 129-132.
1047 Artikel Souney PF, Colucci RD, Mariani G, Campbell D.
Compatibility of magnesium sulfate solutions with various antibiotics during simulated Y-site injection.
Am J Hosp Pharm 1984 ; 41: 323-324.
1057 Artikel Cutie MR.
Compatibility of verapamil hydrochloride injection with commonly used additives.
Am J Hosp Pharm 1983 ; 40: 1205-1207.
1165 Artikel Bowtle WJ, Heasman MJ, Prince AP, Easthope DA.
Compatibility of the cephalosporin, cefamandole nafate with injections.
Int J Pharm 1980 ; 4: 263-265.
1201 Artikel Yuhas EM, Lofton FT, Rosenberg HA, Mayron D, Baldinus JG.
Cimetidine hydrochloride compatibility III: Room temperature stability in drug admixtures.
Am J Hosp Pharm 1981 ; 38: 1919-1922.
1232 Artikel Beatson C, Taylor A.
A physical compatibility study of furosemide & flucloxacillin injections.
Br J Pharm Pract 1987 ; 9: 223-226, 236.
1479 Artikel Digel S.
Cefamandolnafat und metronidazol. Chemische stabilität in einer mischung zur intravenösen infusion.
Krankenhauspharmazie 1995 ; 1: 9-12.
3520 fabrikant Cidomycin - Summary of product Chracteristics.
Sanofi 2011
3526 fabrikant Clindamycin (Dalacin®) - Summary of Product Characteristics
Pharmacia 2010
3546 fabrikant Cefamandole Flavelab - Résumé des caractéristiques du produit
Panpharma SA 2007
3549 fabrikant Amikacine B Braun - Résumé des caractéristiques du produit.
B Braun 2012
3594 fabrikant Metronidazole (Flagyl®) - Summary of Product Characteristics
Zentiva 2013
3643 fabrikant Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics
Sanofi 2015
3644 fabrikant Calcium gluconate® - Summary of Product Characteristics
Hameln Pharmaceuticals 2010
3674 fabrikant Erythromycin lactobionate - Summary of Product Characteristics
PanPharma 2016

  Mentions Légales